Brain activity was assessed two times during the postpartum period using fMRI and the Go/NoGo task. ROI analyses show decreased activations during the late compared to the early postpartum period. Whole-brain analysis reveals decreased activation among postpartum women compared to controls. 
Introduction
The postpartum period is characterized by complex hormonal changes [1] and numerous neuroendocrine alterations, including suppression of the hypothalamic-pituitary-adrenal (HPA) axis [2] , attenuated serotonergic activity [3, 4] , increased monoamine supports the idea that changes in cognitive function occurs during pregnancy and the postpartum period (for example see Ref. [21] ). While numerous hormonal factors may influence cognitive function during the peripartum period [21] , estrogen has attracted particular attention due to its influence on a number of cognitive domains such as spatial memory, learning, and several executive tasks, including both working memory and attention [22] . However, the effect of transition into motherhood on inhibitory control, another important aspect of executive function, has not been studied.
The Go/NoGo task tests inhibitory control by measuring the ability of participants to refrain from making a learned or prepotent response (response inhibition). Together with functional magnetic resonance imaging (fMRI), the Go/NoGo task has been used to examine response inhibition in healthy participants [23] . The successful execution of a response inhibition consistently involves the prefrontal cortex [23] [24] [25] and sex-related activation differences [23] as well as ovarian steroid influences (commonly assessed across the menstrual cycle) have been demonstrated [24, [26] [27] [28] . More specifically, the neuroanatomical areas activated during response inhibition that appear responsive to ovarian hormones include the orbitofrontal cortex (OFC), inferior frontal gyrus, anterior cingulate cortex (ACC), precentral gyrus, culmen, putamen, and precuneus [24, [26] [27] [28] .
Because of the lack of imaging studies addressing the normal cognitive changes across the postpartum period in healthy women, the aim of this study was to examine response inhibition and its neural correlates in healthy postpartum women. Postpartum women were assessed at two time-points during the postpartum period (immediately following delivery and 4-6 weeks postpartum) and were also compared to non-postpartum controls. Because of the dramatic drop in estradiol and progesterone serum concentrations following delivery [1] and the abundance of ovarian steroid receptors throughout the brain, especially in areas involved in cognitive processing [29] [30] [31] [32] [33] , we focused on a number of ovarian steroid-influenced regions of importance for response inhibition [24, [26] [27] [28] .
Methods

Participants
Twenty-six right-handed healthy postpartum women were included in the study after recruitment at the Maternity ward of the Department of Obstetrics and Gynecology, Uppsala University Hospital. Women between 18 and 45 years, with a normal pregnancy, uncomplicated delivery (vaginal deliveries as well as caesarean sections), and at least one night of sleep following delivery were included in the study. Exclusion criteria were ongoing depression or anxiety disorders according to the Swedish version of the Mini International Neuropsychiatric Interview (M.I.N.I) [34] , treatment with hormonal compounds or psychotropic drugs (including serotonin reuptake inhibitors and benzodiazepines) within three months prior to inclusion, neurologic disorders, previous brain trauma, postpartum complications, and women with children admitted to neonatal care. Additional exclusion criteria according to the guidelines from the Centre for Medical Imaging, Uppsala University Hospital, were use of a pacemaker, defibrillator, clips for aneurysms or any other metal implantations, visual impairment (>5 degrees myopic/hyperopic or profound astigmatism), and weight more than 150 kg.
In addition, 13 non-postpartum healthy women were included in the study as controls. The non-postpartum controls had self-reported regular menstrual cycles (25-31 days) and did not use hormonal contraceptive methods. Similar exclusion criteria as for postpartum women were applied with the addition of ongoing pregnancy, breast feeding and self-reported premenstrual symptoms (subsequently verified by one month of prospective daily ratings of premenstrual symptoms). The non-postpartum controls have been included in one of our previous studies [28] .
All participants provided written informed consent prior to inclusion and the procedures were approved by the Regional Ethical Review Board, Uppsala, Sweden.
Study design
All women were scheduled to participate in two fMRI-sessions. Postpartum women were tested within 48 hours after delivery (early postpartum) and then 4 and 6 weeks after delivery (late postpartum). The scanning sessions were scheduled to correspond with the relatively high and low levels of circulating ovarian hormones in the early postpartum and late postpartum phases, respectively [35] . Non-postpartum controls were tested once in the follicular phase (postmenstrual day [6] [7] [8] [9] [10] [11] [12] and once in the late luteal phase (postovulatory day [8] [9] [10] [11] [12] [13] [14] of the menstrual cycle. To avoid test order effects across the menstrual cycle, half of the non-postpartum controls were scheduled to start in the follicular phase, while the remaining controls started in the late luteal phase, for further details, see [28] . As no test-order effects were evident in the non-postpartum controls it was considered feasible to include them as controls to the postpartum women, where scanning sessions, for obvious reasons, could not be counterbalanced.
Blood samples to measure estradiol and progesterone concentrations were taken in all subjects. For technical reasons, allopregnanolone serum concentrations were only determined in the postpartum women.
Hormonal analyses
Serum progesterone and estradiol levels were analyzed by competitive immunometry electrochemistry luminescence detection at the Department of Medical Sciences, Uppsala University hospital. The samples were run on a Roche Cobas e601 with Cobas Elecsys estradiol and progesterone reagent kits respectively (Roche Diagnostics, Bromma, Sweden). For progesterone the measurement interval was 0.1-191 nmol/l and for estradiol 18.4-15781 pmol/l. The progesterone intra-assay coefficient of variation was 2.2% at 2.4 nmol/l and 2.8% at 31.6 nmol/l, while the estradiol intra-assay coefficient of variation was 6.8% at 85.5 pmol/l and 2.8% at 1640 pmol/l. Serum allopregnanolone was measured using radioimmunoassay (RIA) after extraction with diethyl ether and purification by high performance chromatography (HPLC). The antibody used was raised against 3␣-hydroxy-20-oxo-5␣-pregnan-11-yl carboxymethyl ether coupled with bovine serum albumin as antigen (AgriSera AB, Umeå, Sweden). Because of the cross reactivity of the antibody, separation by HPLC was performed prior to the RIA. All samples were counted in a RackBeta (Wallace, Finland) scintillation counter. The RIA and extraction procedure [36] as well as the HPLC procedure [37] has been described previously.
fMRI Go/NoGo task
The Go/NoGo task consisted of 250 stimulus presentations (225 Go-stimuli and 25 NoGo-stimuli), with 600 ms durations and 400 ms interstimulus intervals. The participants were instructed to press a button whenever the letters (X or Y, white letters on black background) were presented (Go-stimuli), but to refrain from pressing the button when the same letter was presented two times in a row, i.e. inhibiting the response (NoGo-stimuli). Correct response to Go-stimuli was defined as finger press within 600 ms, while correct performance to NoGo-stimuli was the withholding of a finger press (i.e. correct inhibition). An incorrect response to a Go-stimulus was defined as no finger press within 1 s, whereas an incorrect response to a NoGo stimulus was defined as a finger press on NoGo-stimuli. The proportion of Go-to NoGo-stimuli was selected in order to reduce the expectancy of NoGo-stimuli and to provoke a high error rate. All participants performed a training task before each scanning session to ensure that they understood the instructions.
Image acquisition
All MR imaging was performed with a whole body 3 T scanner equipped with an 8 channel head coil (Achieva 3T X-series, Philips Medical Systems, Best, the Netherlands). An anatomical reference data set was acquired for each patient with a T1 weighted inversion recovery sequence; 60 slices with no interslice spacing, field of view 230 mm × 230 mm, voxel size 0.8 mm × 1.0 mm × 2.0 mm, repetition time 5700 ms, echo time 15 ms and inversion time 400 ms. BOLD images were acquired using a conventional single shot echo planar imaging sequence; 30 slices with 1.0 mm interslice spacing, field of view 230 mm × 230 mm, voxel size 3.0 mm × 3.0 mm × 3.0 mm, temporal resolution 3000 ms and echo time 35 ms. The visual stimuli were presented to the participant with a pair of head coil mounted goggles and finger press responses were collected using a hand held controller, both part of a commercial hardware package for fMRI (NordicNeuroLab, Bergen, Norway).
Processing of BOLD images and fMRI analysis
All image processing and fMRI analyses were conducted using Statistical Parametric Mapping (SPM5) (http://www.fil.ion.ucl.ac.uk/spm/software/spm5/). Reorientation of the blood oxygen level dependent (BOLD) images was performed using the parameters obtained through manual reorientation of the anatomical image, with the origin set in the anterior commissure. Spatial realignment, to correct for head motion, was performed using the mean image of all BOLD images as a template. Slice timing correction was performed to account for differences in acquisition time for the individual slices within each whole brain volume using the middle slice of the brain as a template. To transform each individual brain into MNI-space, the BOLD images were co-registered with the anatomical image which then was segmented into white matter, grey matter, and cerebrospinal fluid. The normalization parameters obtained from this procedure were used to normalize the BOLD images and finally, spatial smoothing was performed using a kernel of 8 mm.
For each participant BOLD signal changes were regressed against the six movement parameter time-series and time-series contrasts to each condition (correct/incorrect Go and correct/incorrect NoGo) of the Go/NoGo task were created. For the subsequent analyses of brain activity during response inhibition, the NoGo to Go stimuli contrast (i.e. correct NoGo > correct Go) was used, while other contrasts were not considered relevant for the purpose of the current study.
Statistical analyses
A whole-brain one-sample t-test including both groups and test sessions was used to assess the main effect of the Go/NoGo task. According to the a priori hypothesis of ovarian steroid influence among postpartum women the bilateral OFC, inferior frontal gyri, ACC, precentral gyri, culmen, putamen and precuneus were analyzed using a region of interest (ROI) approach. The ROIs were defined by automated anatomical labeling in the WFU PickAtlas toolbox for SPM [38] and a paired-samples t-test (for the longitudinal analyses in postpartum women) with a statistical threshold of p < 0.05 corrected for search volume of the ROI and an extent threshold of ten contiguous voxels, was performed.
To compare postpartum women and controls, the ROIs were modeled through a voxel-wise two-way ANOVA with session (early vs. late postpartum or luteal vs. follicular phase of the menstrual cycle) as a within-group variable and group (postpartum women vs. healthy controls) as a between-group variable using the same statistical threshold as in the paired t-test. To allow as comparable hormonal levels as possible, early postpartum women were compared with luteal phase controls, whereas late postpartum women were compared with follicular phase controls in the ANOVA. However, all SPM analyses were also modeled in a separate ANOVA with early postpartum women compared to follicular phase controls, and late postpartum women compared to luteal phase controls. This procedure did not alter the overall results, why the planned comparison was considered feasible.
Performance during the Go/NoGo task was analyzed by repeated measures ANOVA and between-group comparisons of baseline characteristics were made by independent t-tests or Mann-Whitney U-tests. Within subject comparisons of hormone levels were assessed using the Wilcoxon signed ranks test. Correlations with the serum hormone concentrations were conducted on the mean extracted ROI activity in arbitrary units at the early and late postpartum assessment by use of the Spearman Rank correlation with Bonferroni correction for multiple comparisons. All analyses, including demographic characteristics, were performed using IBM SPSS, version 20.0 (IBM Corporation, Somer, NY, USA). All values in the text are displayed as mean ± standard deviation (SD) unless otherwise stated.
Results
Of the twenty-six postpartum women included, eight could not be examined within the 48 h time-frame due to lack of access to the fMRI equipment. One participant dropped out of the study after the first test session and four additional participants were excluded; two participants because of claustrophobic symptoms while in the scanner, one for medical reasons, and one participant due to lack of correct NoGo-trials. Hence, 13 postpartum women were included in the final analyses. Of the 13 postpartum women included, seven (53.8%) were delivered vaginally and six were delivered with caesarean section. The first scanning was performed 28 ± 10 h after delivery and the second scanning 34 ± 5 days after delivery. At the time of the second scanning, all postpartum women were breastfeeding. Demographic data of postpartum women and nonpostpartum controls are given in Table 1 . Postpartum women were Table 1 Demographic data, presented as mean ± standard deviation or n (%).
Postpartum women n = 13
Non-postpartum controls n = 13 c Age (years) 32.5 ± 4.1 34.9 ± 8.6 Parity (n)
1.8 ± to a greater extent married or cohabiting than non-postpartum controls, otherwise no differences between groups were found.
As expected, estradiol, progesterone, and allopregnanolone serum concentrations decreased from the early to the late postpartum assessment. Estradiol and progesterone serum concentrations were significantly higher in early postpartum women than in healthy controls and significantly lower in late postpartum women than in healthy controls, Table 2 .
Performance on the Go/NoGo task
Postpartum women made more correct responses to Go-stimuli at the late postpartum assessment than in the early postpartum, but response inhibition (correct inhibition to NoGo) did not differ between the postpartum assessments, Table 2 . No differences in correct responses to Go-stimuli or correct inhibition to NoGo were evident between postpartum women and non-postpartum controls, Table 2 . Similarly, no differences between test sessions or groups in reaction times to correct Go-and incorrect NoGo-stimuli were found, Table 2 .
fMRI
Correct inhibition to NoGo trials activated brain areas which are typically activated during performance of response inhibition tasks. These areas included the left inferior frontal gyrus, right superior frontal gyrus, right precentral gyrus, right subcallosal gyrus, right ACC, left cingulate gyrus (two loci in Brodmann area (BA) 23 and 31, respectively), right posterior cingulate gyrus, left parahippocampal gyrus, right angular gyrus, right superior and middle temporal gyri, left fusiform gyrus and left precuneus, data not shown.
Differences between the early and late postpartum assessment
Because of the a priori hypothesis that changes in ovarian steroid levels during the postpartum period would be associated with brain activity changes in ovarian steroid sensitive task-related areas, ROI t-test analyses of the bilateral OFC, inferior frontal gyri, ACC, precentral gyri, culmen, putamen and precuneus were conducted in the postpartum women. These ROI analyses revealed significantly decreased activations in the right inferior frontal gyrus, right ACC, and bilateral precentral gyri (BA 6) among late postpartum women compared with their early postpartum scanning, Table 3 and Fig. 1 . Late postpartum women also displayed significantly increased activation in the left precentral gyrus (BA 9), in comparison with their early postpartum scanning, Table 3 . When delivery mode (vaginal vs. caesarean) was adjusted for using the mean extracted ROI activity and a paired samples t-test, the activations discovered with the ROI-analyses were still significant, data not shown.
There were no correlations between estradiol-, progesteroneand allopregnanolone serum concentrations and the extracted mean ROI activity at the early or late postpartum assessment, Table 4 .
Differences between postpartum women and non-postpartum controls
No areas above the statistical threshold were evident when comparing the first and second test session in the non-postpartum controls. As no test-order effects were evident in the nonpostpartum controls, it was considered feasible to include them as controls to the postpartum women, where scanning sessions, for obvious reasons, could not be counterbalanced.
The ROI analyses also revealed that postpartum women generally had lower activity in the bilateral inferior frontal gyri and right precentral gyrus (two foci) than non-postpartum controls, Table 5 . Table 2 Hormonal status and behavioral data at the time of each scanning session, data presented as mean ± SD.
Postpartum women n = 13
Non-postpartum controls n = 13 
a Data missing in three postpartum women from the first session. b Significantly different from follicular and luteal phase controls, p < 0.01-0.001. c Significantly higher compared to follicular phase controls, p < 0.01. d Some of the data on the non-pregnant controls has been reported previously in Ref. [29] . 
Table 4
Correlations between serum estradiol-, progesterone-, or allopregnanolone concentrations and extracted mean ROI activity at the early and late postpartum assessments. No group by time point interactions were found, independently of how the two-way ANOVA was modeled in SPM.
Discussion
No difference in performance during response inhibitio (correct inhibition to NoGo) was detected across the postpartum period or between the postpartum women and non-postpartum controls. Even so, decreased activation in task-related and ovarian steroidinfluenced areas, such as the right inferior frontal gyrus, right ACC and bilateral precentral gyrus, was found during the late postpartum phase and the postpartum women also displayed lower activity in the inferior frontal gyri and right precentral gyrus in comparison with healthy controls.
The inferior frontal gyrus is involved in a number of functions important for social interaction, for instance speech processing, verbal language production, empathy, and motor execution [39] . Motor tasks with great difficulty or high demand on selective attention, such as the Go/NoGo task, have also been shown to activate the bilateral inferior frontal gyri [39] [40] [41] [42] . The ACC, on the other hand, can be subdivided into an affective and cognitive division where the dorsal part of BA 32, seen in this study, belongs to the cognitive division. The cognitive division of ACC is activated by cognitively demanding tasks without emotional content and has been subscribed a number of functions including the modulation of attention and executive function, conflict monitoring, complex motor control, motivation, novelty, error detection, working memory, and anticipation of cognitively demanding tasks [43] . Together with the precentral gyrus (which is involved in motor control and attention), the late postpartum period was characterized by lower activity during correct response inhibition (correct NoGo > correct Go) in these areas. As behavioral performance during correct NoGo trials did not differ between time-points, it is difficult to judge if the decrease in prefrontal brain activation between early and late postpartum assessment, as well as between non-postpartum controls and postpartum women reflects reduced effort, increased neural efficiency or an inappropriate recruitment of resources required for correct NoGo responses.
None of the significant ROIs correlated with ovarian steroid or neurosteroid serum concentrations. However, this finding should not be taken as evidence that ovarian steroid levels are not important for the overall results. The ovarian steroid changes across pregnancy and postpartum are far greater than for any other hormonal system but inter-individual differences are great and may preclude more direct associations [44] . In addition, compensatory receptor turnover changes in the brain may not yet have taken place when the early postpartum women were evaluated (on average 28 h after delivery). Following parturition, expression changes in estradiol, progesterone or oxytocin receptors occur within 6 h to 2 days, depending on receptor type and brain region in female rats [45] [46] [47] [48] , but the corresponding receptor turnover time-course following human delivery is essentially unknown. Other hormone sensitive tasks that reflect brain function, such as prepulse inhibition [49, 50] , is reduced in pregnant women and not yet normalized in the early postpartum period [51] . Thus, it is possible that brain activity in early postpartum women is more reflective of the pregnant rather than the postpartum brain although this is not reflected by the serum concentrations of ovarian hormones. Our findings in postpartum women are also in line with studies examining the menstrual cycle effects on brain activity during response inhibition. In comparison with the luteal phase (representing a state of high levels of ovarian steroids), reduced ACC [27] and inferior frontal gyrus activity has been reported in the follicular phase [24, 27] .
While this study set out to unravel potentially important cognitive aspects of the postpartum period that might be influenced by changes in ovarian steroid levels, it should be acknowledged that the different activation patterns across the postpartum period may as well be related to HPA axis hypo-responsiveness [52] or to increased levels of oxytocin [53] . However, average plasma oxytocin levels does not increase during the postpartum period compared to pregnancy levels [54] , only during nursing [55] . Furthermore, oxytocin does not cross the blood-brain barrier [56] , why it is difficult to assess the importance of peripheral oxytocin levels in studies examining brain function. Nevertheless, this study would have been strengthened if cortisol and oxytocin plasma levels would have been available.
The study is limited by the relatively small sample size, but represents the first attempt to describe the neuroanatomical correlates of cognitive control in the postpartum period of healthy, non-depressed women. However, it must be emphasized that generalizations to newly delivered women may be hampered by the fact that women in this study were highly motivated, welleducated, and had physically and psychologically uncomplicated deliveries and postpartum periods. Also, the study would have been strengthened by a more uniform group of only vaginally delivered women, even though the study did not detect any activation differences between women who had had a vaginal or caesarean delivery.
Conclusion
In conclusion, this study has revealed that brain activity in certain prefrontal areas during a response inhibition task decreases throughout the course of the first postpartum weeks and is lower than in non-postpartum controls. Normal pregnancy and the postpartum period bring about adaptive endocrine changes [57] which would otherwise be considered pathological in nonpregnant women. Our findings add information to the complexity of the postpartum period, and may help to explain why this specific period in life is associated with increased susceptibility to depressive and anxiety disorders. Further studies on the normal adaptive brain activity changes that occur during the postpartum period are warranted.
